TrialEuropean journal of medical research2023

Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy.

Yudi Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.